Cargando…

Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia

Epidemiological studies have consistently shown elevated rates of breast cancer among female blood relatives of patients with ataxia telangiectasia (AT), a rare autosomal recessive disease. A large proportion of the members of AT families are carriers of AT-causing gene mutations in ATM (Ataxia Tela...

Descripción completa

Detalles Bibliográficos
Autores principales: Olsen, J H, Hahnemann, J M D, Børresen-Dale, A-L, Tretli, S, Kleinerman, R, Sankila, R, Hammarström, L, Robsahm, T E, Kääriäinen, H, Bregård, A, Brøndum-Nielsen, K, Yuen, J, Tucker, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361547/
https://www.ncbi.nlm.nih.gov/pubmed/15942625
http://dx.doi.org/10.1038/sj.bjc.6602658
_version_ 1782153238780313600
author Olsen, J H
Hahnemann, J M D
Børresen-Dale, A-L
Tretli, S
Kleinerman, R
Sankila, R
Hammarström, L
Robsahm, T E
Kääriäinen, H
Bregård, A
Brøndum-Nielsen, K
Yuen, J
Tucker, M
author_facet Olsen, J H
Hahnemann, J M D
Børresen-Dale, A-L
Tretli, S
Kleinerman, R
Sankila, R
Hammarström, L
Robsahm, T E
Kääriäinen, H
Bregård, A
Brøndum-Nielsen, K
Yuen, J
Tucker, M
author_sort Olsen, J H
collection PubMed
description Epidemiological studies have consistently shown elevated rates of breast cancer among female blood relatives of patients with ataxia telangiectasia (AT), a rare autosomal recessive disease. A large proportion of the members of AT families are carriers of AT-causing gene mutations in ATM (Ataxia Telangiectasia Mutated), and it has been hypothesised that these otherwise healthy carriers are predisposed to breast cancer. This is an extended and enlarged follow-up study of cancer incidence in blood relatives of 75 patients with verified AT in 66 Nordic families. Blood relatives were identified through population registry linkages, and the occurrence of cancer was determined from cancer registry files in each country and compared with national incidence rates. The ATM mutation carrier probabilities of relatives were assigned from the combined information on location in family, consanguinity, if any, and supplementary carrier screening in some families. Among the 1445 blood relatives of AT patients, 225 cancers were observed, with 170.4 expected, yielding a standardised incidence ratio (SIR) of 1.3 (95% confidence interval (CI), 1.1–1.4). Invasive breast cancer occurred in 34 female relatives (SIR, 1.7; 95% CI, 1.2–2.4) and was diagnosed in 21 women before the age of 55 years (SIR, 2.9; 95% CI, 1.8–4.5), including seven mothers of probands (SIR, 8.1; 95% CI, 3.3–17). When the group of mothers was excluded, no clear relationship was observed between the allocated mutation carrier probability of each family member and the extent of breast cancer risk. We concluded that the increased risk for female breast cancer seen in 66 Nordic AT families appeared to be restricted to women under the age of 55 years and was due mainly to a very high risk in the group of mothers. The findings of breast cancer risk in mothers, but not other likely mutation carriers, in this and other studies raises questions about the hypothesis of a simple causal relationship with ATM heterozygosity.
format Text
id pubmed-2361547
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23615472009-09-10 Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia Olsen, J H Hahnemann, J M D Børresen-Dale, A-L Tretli, S Kleinerman, R Sankila, R Hammarström, L Robsahm, T E Kääriäinen, H Bregård, A Brøndum-Nielsen, K Yuen, J Tucker, M Br J Cancer Genetics and Genomics Epidemiological studies have consistently shown elevated rates of breast cancer among female blood relatives of patients with ataxia telangiectasia (AT), a rare autosomal recessive disease. A large proportion of the members of AT families are carriers of AT-causing gene mutations in ATM (Ataxia Telangiectasia Mutated), and it has been hypothesised that these otherwise healthy carriers are predisposed to breast cancer. This is an extended and enlarged follow-up study of cancer incidence in blood relatives of 75 patients with verified AT in 66 Nordic families. Blood relatives were identified through population registry linkages, and the occurrence of cancer was determined from cancer registry files in each country and compared with national incidence rates. The ATM mutation carrier probabilities of relatives were assigned from the combined information on location in family, consanguinity, if any, and supplementary carrier screening in some families. Among the 1445 blood relatives of AT patients, 225 cancers were observed, with 170.4 expected, yielding a standardised incidence ratio (SIR) of 1.3 (95% confidence interval (CI), 1.1–1.4). Invasive breast cancer occurred in 34 female relatives (SIR, 1.7; 95% CI, 1.2–2.4) and was diagnosed in 21 women before the age of 55 years (SIR, 2.9; 95% CI, 1.8–4.5), including seven mothers of probands (SIR, 8.1; 95% CI, 3.3–17). When the group of mothers was excluded, no clear relationship was observed between the allocated mutation carrier probability of each family member and the extent of breast cancer risk. We concluded that the increased risk for female breast cancer seen in 66 Nordic AT families appeared to be restricted to women under the age of 55 years and was due mainly to a very high risk in the group of mothers. The findings of breast cancer risk in mothers, but not other likely mutation carriers, in this and other studies raises questions about the hypothesis of a simple causal relationship with ATM heterozygosity. Nature Publishing Group 2005-07-25 2005-06-07 /pmc/articles/PMC2361547/ /pubmed/15942625 http://dx.doi.org/10.1038/sj.bjc.6602658 Text en Copyright © 2005 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Genetics and Genomics
Olsen, J H
Hahnemann, J M D
Børresen-Dale, A-L
Tretli, S
Kleinerman, R
Sankila, R
Hammarström, L
Robsahm, T E
Kääriäinen, H
Bregård, A
Brøndum-Nielsen, K
Yuen, J
Tucker, M
Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia
title Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia
title_full Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia
title_fullStr Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia
title_full_unstemmed Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia
title_short Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia
title_sort breast and other cancers in 1445 blood relatives of 75 nordic patients with ataxia telangiectasia
topic Genetics and Genomics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361547/
https://www.ncbi.nlm.nih.gov/pubmed/15942625
http://dx.doi.org/10.1038/sj.bjc.6602658
work_keys_str_mv AT olsenjh breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia
AT hahnemannjmd breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia
AT børresendaleal breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia
AT tretlis breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia
AT kleinermanr breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia
AT sankilar breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia
AT hammarstroml breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia
AT robsahmte breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia
AT kaariainenh breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia
AT bregarda breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia
AT brøndumnielsenk breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia
AT yuenj breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia
AT tuckerm breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia